Episode notes
This week, we have conversations with Sjanna Bosma, international relations officer at Health Holland; Mark Bagnall, CEO of Phenomix; and PDS Biotechnology CEO Frank Bedu-Addo.
04:17 Phenomix
32:53 Health Holland
44:02 PDS Biotechnology
Phenomix takes on obesity
Phenomix Sciences is a biotechnology company focused on precision obesity medicine. The firm has developed the MyPhenome test, a saliva‑based assay that uses machine‑learning algorithms and genetic risk scores to classify obesity phenotypes and predict treatment outcomes.
The company positions itself as the first commercial precision obesity medicine biotech, aiming to improve patient stratificati ...
Keywords
biotechbiotechnologycancerlife sciencesobesityNetherlandsPhenomixHealth HollandPDS Biotechnology